Nadja Angela Stenz1, Susanne Stampf2, Andreas W Arnold3, Antonio Cozzio4, Michael Dickenmann5, Olivier Gaide6, Mirjam Harms1, Robert E Hunger7, Emmanuel Laffitte8, Michael Mühlstädt8, Mirjam Nägeli1, Günther F L Hofbauer9. 1. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. 2. Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland. 3. Department of Dermatology, University Basel and Dermatologie am Rhein, Basel, Switzerland. 4. Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland. 5. Division of Transplant Immunology and Nephrology, University Hospital Basel, Basel, Switzerland. 6. Department of Dermatology, University Hospital of Lausanne, Lausanne, Switzerland. 7. Department of Dermatology, Inselspital, University Hospital Berne, Berne, Switzerland. 8. Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland. 9. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland, gfl@hofbauer.ch.
Abstract
IMPORTANCE: Skin cancer, in particular squamous cell carcinoma, is the most frequent malignancy among solid organ transplant recipients with a higher incidence compared to the general population. OBJECTIVE: To determine the skin cancer incidence in organ transplant recipients in Switzerland and to assess the impact of immunosuppressants and other risk factors. DESIGN: Prospective cohort study of solid organ transplant recipients in Switzerland enrolled in the Swiss Transplant Cohort Study from 2008 to 2013. PARTICIPANTS: 2,192 solid organ transplant recipients. MATERIALS AND METHODS: Occurrence of first and subsequent squamous cell carcinoma, basal cell carcinoma, melanoma and other skin cancers after transplantation extracted from the Swiss Transplant Cohort Study database and validated by medical record review. Incidence rates were calculated for skin cancer overall and subgroups. The effect of risk factors on the occurrence of first skin cancer and recurrent skin cancer was calculated by the Cox proportional hazard model. RESULTS: In 2,192 organ transplant recipients, 136 (6.2%) developed 335 cases of skin cancer during a median follow-up of 32.4 months, with squamous cell carcinoma as the most frequent one. 79.4% of skin cancer patients were male. Risk factors for first and recurrent skin cancer were age at transplantation, male sex, skin cancer before transplantation and previous transplantation. For a first skin cancer, the number of immunosuppressive drugs was a risk factor as well. CONCLUSIONS AND RELEVANCE: Skin cancer following solid organ transplantation in Switzerland is greatly increased with risk factors: age at transplantation, male sex, skin cancer before transplantation, previous transplantation and number of immunosuppressive drugs.
IMPORTANCE: Skin cancer, in particular squamous cell carcinoma, is the most frequent malignancy among solid organ transplant recipients with a higher incidence compared to the general population. OBJECTIVE: To determine the skin cancer incidence in organ transplant recipients in Switzerland and to assess the impact of immunosuppressants and other risk factors. DESIGN: Prospective cohort study of solid organ transplant recipients in Switzerland enrolled in the Swiss Transplant Cohort Study from 2008 to 2013. PARTICIPANTS: 2,192 solid organ transplant recipients. MATERIALS AND METHODS: Occurrence of first and subsequent squamous cell carcinoma, basal cell carcinoma, melanoma and other skin cancers after transplantation extracted from the Swiss Transplant Cohort Study database and validated by medical record review. Incidence rates were calculated for skin cancer overall and subgroups. The effect of risk factors on the occurrence of first skin cancer and recurrent skin cancer was calculated by the Cox proportional hazard model. RESULTS: In 2,192 organ transplant recipients, 136 (6.2%) developed 335 cases of skin cancer during a median follow-up of 32.4 months, with squamous cell carcinoma as the most frequent one. 79.4% of skin cancer patients were male. Risk factors for first and recurrent skin cancer were age at transplantation, male sex, skin cancer before transplantation and previous transplantation. For a first skin cancer, the number of immunosuppressive drugs was a risk factor as well. CONCLUSIONS AND RELEVANCE: Skin cancer following solid organ transplantation in Switzerland is greatly increased with risk factors: age at transplantation, male sex, skin cancer before transplantation, previous transplantation and number of immunosuppressive drugs.
Authors: Christoph Berger; Pierre-Yves Bochud; Katja Boggian; Alexia Cusini; Adrian Egli; Christian Garzoni; Hans H Hirsch; Matthias Hoffmann; Nina Khanna; Oriol Manuel; Pascal Meylan; David Nadal; Christian van Delden; Maja Weisser; Nicolas J Mueller Journal: Curr Infect Dis Rep Date: 2015-06 Impact factor: 3.725
Authors: Britta Krynitz; Gustaf Edgren; Bernt Lindelöf; Eva Baecklund; Christina Brattström; Henryk Wilczek; Karin E Smedby Journal: Int J Cancer Date: 2012-08-28 Impact factor: 7.396
Authors: G F L Hofbauer; N R Attard; C A Harwood; J M McGregor; P Dziunycz; G Iotzova-Weiss; G Straub; R Meyer; Y Kamenisch; M Berneburg; L E French; R P Wüthrich; P Karran; A L Serra Journal: Am J Transplant Date: 2011-09-22 Impact factor: 8.086
Authors: Michael T Koller; Christian van Delden; Nicolas J Müller; Philippe Baumann; Christian Lovis; Hans-Peter Marti; Thomas Fehr; Isabelle Binet; Sabina De Geest; Heiner C Bucher; Pascal Meylan; Manuel Pascual; Jürg Steiger Journal: Eur J Epidemiol Date: 2013-04-02 Impact factor: 8.082
Authors: Susanne Stampf; Nicolas J Mueller; Christian van Delden; Manuel Pascual; Oriol Manuel; Vanessa Banz; Isabelle Binet; Sabina De Geest; Pierre-Yves Bochud; Alexander Leichtle; Stefan Schaub; Jürg Steiger; Michael Koller Journal: BMJ Open Date: 2021-12-15 Impact factor: 2.692